Back to clinical trials listLung cancer

CONVERGE

A Phase 2, randomized, open-label, active-controlled study of JNJ-90301900 in;combination with chemoradiation followed by durvalumab in locally advanced and;unresectable Stage III non-small cell lung cancer

Open at Paris since : 21/10/2025
Target : Adult
Phase : Phase II

Trial description

A Phase 2 study of JNJ-90301900 with chemoradiation and durvalumab for non-small cell;lung cancer

Url of the trial

Main investigator

NICOLAS GIRARD

Professeur - Médecin

Contact